Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.


Apr 21, 2016

India Patent Office Decision Denying Cipla's Patent Application for an Anti-Retroviral Combination

This post examines the April 1, 2016 decision issued by the Indian Patent Office involving patent application 1399/MUMNP/2010 entitled, "Anti-retroviral Combination", (the '1399 application) owned by Cipla Limited. The '1399 application was filed on June 30, 2010, and claims a pharmaceutical composition for treating HIV comprising ritonavir and darunavir. The application was filed with the […]
back to top